Home LiteratureArticle Details
PMID: 16700027 Published · ppublish English Case Reports Journal Article Research Support, Non-U.S. Gov't

PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism.

Movement disorders : official journal of the Movement Disorder Society ·Vol. 21 ·No. 8 ·2006-08-00 ·Pages 1265-7

Criscuolo C, Volpe G, De Rosa A, Varrone A, Marongiu R, Mancini P, Salvatore E, Dallapiccola B, Filla A, Valente EM, De Michele G

Abstract

We analyzed the PINK1 gene in 58 patients with early-onset Parkinsonism and detected the homozygous mutation W437X in 1 patient. The clinical phenotype was characterized by early onset (22 years of age), good response to levodopa, early fluctuations and dyskinesias, and psychiatric symptoms. The mother, heterozygote for W437X mutation, was affected by Parkinson's disease and 3 further relatives were reported affected, according to an autosomal dominant transmission.

MeSH Terms
Age of Onset Female Homozygote Humans Male Middle Aged Mutation Parkinson Disease/genetics Pedigree Protein Kinases/genetics
Chemicals
Protein Kinases PTEN-induced putative kinase
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Criscuolo Chiara
Department of Neurological Sciences, Federico II University, Naples, Italy.
Volpe Giampiero
De Rosa Anna
Varrone Andrea
Marongiu Roberta
Mancini Pietro
Salvatore Elena
Dallapiccola Bruno
Filla Alessandro
Valente Enza Maria
De Michele Giuseppe
Article Info
Journal
Movement disorders : official journal of the Movement Disorder Society
Abbr.
Mov Disord
ISSN
0885-3185
Published
2006-08-00
Pages
1265-7
Language
English
Region
United States
NLM ID
8610688
Subset
IM
Grants
Telethon · GGP04291 · Italy
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com